Ligand validation:5QJ2

BMA: beta-D-mannopyranose

BMA is a Ligand Of Interest in 5QJ2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QJ2_BMA_B_610	57%	20%	0.116	0.905	1.16	2.19	1	6	3	0	92%	0.9167
5QJ2_BMA_I_602	51%	16%	0.139	0.906	1.36	2.32	2	7	2	0	92%	0.9167
5QJ2_BMA_G_609	45%	11%	0.128	0.874	1.22	2.93	1	5	8	0	92%	0.9167
5QJ2_BMA_E_601	40%	14%	0.17	0.897	1.35	2.46	1	5	5	0	92%	0.9167
6WYD_BMA_B_608	58%	14%	0.138	0.931	1.15	2.71	-	4	4	0	92%	0.9167
5FIW_BMA_D_644	54%	51%	0.1	0.879	0.71	1.17	-	2	3	0	92%	0.9167
7NI3_BMA_C_607	24%	66%	0.162	0.805	0.36	0.94	-	2	0	0	92%	0.9167
7NI1_BMA_D_601	0%	74%	0.474	0.492	0.34	0.67	-	-	0	0	92%	0.9167
5IDB_BMA_A_1003	100%	58%	0.048	0.995	0.68	0.94	-	1	0	0	100%	1
2XJP_BMA_A_1278	98%	53%	0.062	0.981	0.69	1.1	-	2	1	0	100%	0.45
2GUD_BMA_A_123	96%	60%	0.07	0.981	0.56	0.97	-	-	0	0	100%	0.25
5A7V_BMA_A_1385	95%	45%	0.07	0.976	0.76	1.34	1	3	0	0	100%	0.5
4CD4_BMA_A_1422	95%	68%	0.07	0.988	0.52	0.69	-	-	0	0	92%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.